EMA extends review of antivirals for hepatitis C The European Medicines Agency is extending its review of direct-acting antiviral treatments for hepatitis C to look at evidence that shows they are associated with liver cancer recurrence.…
EMA to review safety of direct-acting antivirals after reports of hepatitis B reactivation The European Medicines Agency is to review the safety of direct-acting antivirals used to treat patients with chronic hepatitis C infection.…
Pharmaceutical Care Awards 2015 audience choice winnersThe audience choice winners explain why their Pharmaceutical Care Awards project should be replicated.…
Blood borne virus project wins ‘most reproducible’ audience vote at Pharmaceutical Care Awards The audience choice award was presented to a community pharmacy project that focused on testing for hepatitis B, hepatitis C and HIV in the Isle of Wight.…
Beethoven’s musical electrocardiogramsCould Beethoven have suffered from cardiac arrhythmia? His music suggests he could have.…
Community pharmacists could screen at-risk groups for liver disease According to The Lancet’s commission, community pharmacists could play a key role in helping to improve liver disease services in primary care, say hepatology specialists.…
